ArticleBMC cancer2019

Afatinib helped overcome subsequent resistance to osimertinib in a patient with NSCLC having leptomeningeal metastasis baring acquired EGFR L718Q mutation: a case report.

Jing Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.